Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | ADH4 | P08319 | 1/20 | 0.42 |
| ▸ | ADH7 | P40394 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22122694 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL5646725 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL16892594 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL10886305 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL8327207 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL16892544 | 1.00 | TSHR (0.52) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL644844 | 0.97 | — | — | |
| SCHEMBL646484 | 0.89 | — | — | |
| SCHEMBL16892555 | 0.82 | EPHX1 (0.58) | TSHRFAAHTRPV1EPHX1ADH1B | |
| SCHEMBL1951524 | 0.82 | EPHX1 (0.52) | TSHRFAAHTRPV1EPHX1ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2894685-B1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DAINIPPON INK & CHEMICALS (JP) | 2018-10-31 | — | — | EP | disclosed |
| US-9490433-B2 | Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor | DIC CORPORATION (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20150228913-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DIC CORPORATION (JP) | 2015-08-13 | — | — | US | disclosed |
| EP-2894685-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DIC Corporation (JP) | 2015-07-15 | — | — | EP | disclosed |
| US-7276600-B2 | Phthalocyanine derivatives and their applications in optical recording media | TSAI YEN CHENG | 2007-10-02 | — | — | US | disclosed |
| US-20060292494-A1 | Novel phthalocyanine derivatives, synthetic process thereof and their applications in optical recording media | TSAI YEN C | 2006-12-28 | — | — | US | disclosed |
| US-20060281026-A1 | Phthalocyanine derivatives and their applications in optical recording media | TSAI YEN C | 2006-12-14 | — | — | US | disclosed |
| EP-1048655-B1 | 1,2-DIHYDRO-2-OXOQUINOLINE DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2004-09-01 | — | — | EP | disclosed |
| EP-1048651-B1 | NITROGEN-CONTAINING TETRACYCLIC COMPOUNDS | TAISHO PHARMACEUTICAL CO LTD (JP) | 2003-05-14 | — | — | EP | disclosed |
| US-6380384-B1 | ANXIOLYTIC AGENTS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-04-30 | — | — | US | disclosed |
| US-20020049323-A1 | 1,2-Dihydro-2-oxoquinoline derivatives | NAKAZATO ATSURO (JP) | 2002-04-25 | — | — | US | disclosed |
| US-6329525-B1 | 1,2-Dihydro-2-oxoquinoline derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2001-12-11 | — | — | US | disclosed |
| US-6281355-B1 | Nitrogen-containing tetracyclic compounds | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2001-08-28 | — | — | US | disclosed |
| EP-1048655-A1 | 1,2-DIHYDRO-2-OXOQUINOLINE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2000-11-02 | — | — | EP | disclosed |
| EP-1048651-A1 | NITROGEN-CONTAINING TETRACYCLIC COMPOUNDS | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2000-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060292494-A1 | Novel phthalocyanine derivatives, synthetic process thereof and their applications in optical recording media | TRPC3, TRPA1, TRPC6 | TSHR 2593/4885FAAH 4818/4885TRPV1 40/4885 |
| US-20020049323-A1 | 1,2-Dihydro-2-oxoquinoline derivatives | NR5A1, SRD5A1, SRD5A2 | TSHR 1513/4885FAAH 1250/4885TRPV1 3189/4885 |
| US-20060281026-A1 | Phthalocyanine derivatives and their applications in optical recording media | CRY2, CACNA1C, CRY1 | TSHR 3982/4885FAAH 3539/4885TRPV1 58/4885 |
| US-20150228913-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | TST, TPST2, TPR | TSHR 2341/4885FAAH 4747/4885TRPV1 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.